‎Personalized gene ‎therapy strategies that ‎adjust CXCL10 expression based on the molecular profile of ‎the individual ‎tumor offer the ‎potential for highly targeted and effective cancer treatments that ‎maximize the ‎immune ‎system’s ability to combat cancer. The gene discussed is CXCL10; the disease is neoplasm.